H.R. 2443 · 114th Congress

To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.

Stage
In committee
Sponsor
Brett Guthrie
Introduced
2015-05-19
Latest action
2015-05-22 · Referred to the Subcommittee on Health.

Action history

  1. 2015-05-22Referred to the Subcommittee on Health.
  2. 2015-05-19Introduced in House
  3. 2015-05-19Referred to the House Committee on Energy and Commerce.